Iborra F - Search Results

1

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Clapé C, Fritz V, Henriquet C, Apparailly F, Fernandez PL, Iborra F, Avancès C, Villalba M, Culine S, Fajas L. Clapé C, et al. Among authors: iborra f. PLoS One. 2009 Oct 26;4(10):e7542. doi: 10.1371/journal.pone.0007542. PLoS One. 2009. PMID: 19855844 Free PMC article.

2

Gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the urothelium: a pilot study.

Culine S, Rebillard X, Iborra F, Mottet N, Faix A, Ayuso D, Pinguet F. Culine S, et al. Among authors: iborra f. Anticancer Res. 2003 Mar-Apr;23(2C):1903-6. Anticancer Res. 2003. PMID: 12820476 Clinical Trial.

3

[Anatomic review of the penis].

Avances C, Iborra F, Bastide C. Avances C, et al. Among authors: iborra f. Prog Urol. 2005 Sep;15(4 Suppl 2):799-800. Prog Urol. 2005. PMID: 16382978 French. No abstract available.

4

[Recommendations: diagnosis of malignant penile tumors].

Avances C, Iborra F, Rocher L, Mottet N. Avances C, et al. Among authors: iborra f. Prog Urol. 2005 Sep;15(4 Suppl 2):810-6. Prog Urol. 2005. PMID: 16382981 Review. French. No abstract available.

5

Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.

Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X. Culine S, et al. Among authors: iborra f. Am J Clin Oncol. 2006 Apr;29(2):148-52. doi: 10.1097/01.coc.0000203753.74851.d5. Am J Clin Oncol. 2006. PMID: 16601433 Clinical Trial.

6

[What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?].

El Demery M, Pouessel D, Avancès C, Iborra F, Rebillard X, Faix A, Ségui B, Delbos O, Ayuso D, Culine S. El Demery M, et al. Among authors: iborra f. Prog Urol. 2006 Jun;16(3):320-3. Prog Urol. 2006. PMID: 16821344 French.

7

Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.

Annicotte JS, Iankova I, Miard S, Fritz V, Sarruf D, Abella A, Berthe ML, Noël D, Pillon A, Iborra F, Dubus P, Maudelonde T, Culine S, Fajas L. Annicotte JS, et al. Among authors: iborra f. Mol Cell Biol. 2006 Oct;26(20):7561-74. doi: 10.1128/MCB.00605-06. Mol Cell Biol. 2006. PMID: 17015477 Free PMC article.

8

Liver metastases in prostate carcinoma: clinical characteristics and outcome.

Pouessel D, Gallet B, Bibeau F, Avancès C, Iborra F, Sénesse P, Culine S. Pouessel D, et al. Among authors: iborra f. BJU Int. 2007 Apr;99(4):807-11. doi: 10.1111/j.1464-410X.2006.06663.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155968

9

[Long-term morbidity of living donor kidney harvesting].

Gres P, Avances C, Iborra F, Mourad G, Guiter J. Gres P, et al. Among authors: iborra f. Prog Urol. 2007 Apr;17(2):194-8. doi: 10.1016/s1166-7087(07)92262-9. Prog Urol. 2007. PMID: 17489317 French.

10

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers.

Culine S, El Demery M, Lamy PJ, Iborra F, Avancès C, Pinguet F. Culine S, et al. Among authors: iborra f. J Urol. 2007 Sep;178(3 Pt 1):844-8; discussion 848. doi: 10.1016/j.juro.2007.05.044. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631339 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page